Generic Imatinib Update
On February 1, 2016, there was a commercial launch of the generic version of imatinib mesylate (Gleevec) which is approved for CML patients by the FDA. As the first to file for generic marketing [...]
31
08, 2016
8
04, 2016
Webcast Provides Perspective on Generic Imatinib
On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”
10
02, 2016
Generic Imatinib Approved in the US for CML: What does it mean for GIST patients?
On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), for CML (Chronic Myeloid Leukemia) was approved by the FDA after the Novartis patent expiration and will become available for the first time in the United States through Sun Pharmaceuticals.
18
01, 2016
LRG Generics Surveys
Generics Perception Survey On September 30, 2015, the Life Raft Group sent out a survey to gather people’s perception on generic drugs. Since the generic version of imatinib will become available on or about February [...]
18
01, 2016
Generics – Frequently Asked Questions
What is a generic drug? A generic drug is identical -- or bioequivalent -- to a brand name (innovator) drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. [...]
18
01, 2016
Generics Resources
Helpful Links Apotex Launches Imatinib Tablets Generic Version of Novartis's Gleevec® with Patient Savings Card Program Novartis settles patent litigation on Gleevec® (imatinib mesylate) with Sun Pharma subsidiary Teva Announces Launch of Generic Gleevec® [...]
18
01, 2016
Generics TKI List
This list provides information of all generic TKIs available on the international markets on the product name, compound name (active ingredient), the name of the respective manufacturer and/or Marketing Authorization Holder (MAH). All information is based [...]
18
01, 2016
Generics
On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec) originally for CML (Chronic Myeloid Leukemia) has been approved by the FDA and became available for the first time in [...]
4
04, 2019
Un Hígado vivo
Monitoreando la salud del hígado con GIST El hígado (liver), ubicado debajo de la caja toráxica derecha, es el órgano interno más grande del cuerpo y actúa como una fábrica que regula la digestión, [...]
24
10, 2022
A Unique Perspective by a Physician Who is a GISTer
Submitted by Dr. Indra Lovko, GISTer & LRG contributor Hello my fellow GI Stromal Tumor patients and caregivers! I was asked by the Life Raft Group staff to write about what it has been [...]
Need a new search?
If you didn't find what you were looking for, try a new search!